Top compounds associated with response to STARD3


Feature Type Standardized
Nominal ANOVA
mRNA temsirolimus CTRPv2 pan-cancer AAC 0.15 0.001
mRNA lapatinib UHNBreast pan-cancer AAC 0.78 0.002
mRNA pac-1 GDSC1000 pan-cancer AAC 0.11 0.002
mRNA manumycin A CTRPv2 pan-cancer AAC 0.099 0.002
mRNA LY317615 GDSC1000 pan-cancer AAC 0.11 0.002
mRNA FH535 GDSC1000 pan-cancer AAC 0.11 0.002
mRNA thapsigargin gCSI pan-cancer AAC -0.16 0.003
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.003
mRNA BYL-719 CTRPv2 pan-cancer AAC 0.14 0.003
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.005
Download CSV